Allswell, a US behavioural health company built for the LGBTQ+ community, has raised $7 million in seed funding to expand an insurance-covered virtual therapy service that its founders say addresses a large and long-overlooked gap in mental health care.
The round was led by Rethink Impact, a venture firm that invests in companies led by women and gender-diverse founders, with participation from new investors Magnify Ventures, Ulu Ventures and Hopelab Ventures. Existing backers Techstars and Amboy Street Ventures also took part.
The seed round follows a $1.3 million pre-seed led by Amboy Street Ventures, bringing Allswell's total funding to $8.3 million.
Built by Founders From the Community
Allswell was founded by Dawn Androphy, its chief executive, and Connor Gordon, its chief technology officer. The pair built the company through Stanford Graduate School of Business's Startup Garage programme, where the team also won a Stanford Impact Founder Fellowship.
Androphy brings more than a decade of LGBTQ+ community organising to the role, alongside earlier experience at Microsoft and Boston Consulting Group. Gordon has more than 10 years of experience in software development and product management, including roles at Redfin and Scout.
Their motivation was personal as much as commercial. "We really just saw a lack of options in particular for LGBTQ adults," Androphy has said of the company's origins.
What Allswell Offers
Allswell provides one-on-one virtual therapy, group programmes and trauma-informed behavioural care. Patients are matched with therapists who either identify as LGBTQ+ or have been screened for relevant experience. The company focuses on depression, anxiety, identity-specific trauma, family dynamics and social transition, and is developing a proprietary PTSD and trauma curriculum designed for the LGBTQ+ community. It plans to add psychiatric medication management next year.
Crucially, Allswell accepts both commercial insurance and Medicaid. That distinguishes it from many specialised therapy services that operate on a cash-pay basis, effectively limiting access to those who can afford to pay out of pocket.
The company currently operates in Washington, D.C., Maryland and Virginia.
Early Results Behind the Round
Allswell launched in spring 2025 and now serves hundreds of active patients, conducting as many as 1,500 billable sessions a month, according to Pulse 2.0. Patients often stay in care for more than a year, compared with an industry benchmark of about six to eight sessions, and revenue per patient reportedly runs three to nine times the industry norm.
The company reports that after 60 days of treatment, 77 per cent of patients showed improvement in anxiety and 71 per cent showed improvement in depression. These outcomes are company-reported and have not been independently verified.
Its growth has relied mainly on Medicaid, with additional commercial insurance agreements now coming online.
Why Investors See a Large Market
Allswell's investors argue that the market for LGBTQ+-focused mental health care is far larger than many assume. "Nobody realizes how big this market is," said Heidi Patel, managing partner at Rethink Impact.
Research consistently shows that LGBTQ+ adults experience higher rates of anxiety, depression and trauma than the general population, often linked to discrimination, family rejection and social stress. The company cites estimates that up to 48 per cent of LGBTQ+ adults may meet diagnostic criteria for PTSD, compared with about 8 per cent of the general population. More than 30 million American adults identify as LGBTQ+, according to the company.
Yet many patients report difficulty finding therapists who understand their experiences, and some say they have faced judgement or misunderstanding in mainstream care settings. Specialised providers argue that culturally competent care improves engagement, and Allswell's retention data suggests patients who find the right fit stay in treatment far longer.
The broader shortage of mental health professionals compounds the problem. Large parts of the United States are officially designated as mental health professional shortage areas, and waiting lists for therapy can stretch for weeks or months even for patients with good insurance. For people on Medicaid, the public health programme for lower-income Americans, options are often narrower still, because many therapists decline public insurance and its lower reimbursement rates. By building its business around Medicaid from the outset, Allswell has targeted the part of the market where unmet need is arguably greatest, while also demonstrating to commercial insurers that specialised care can keep patients engaged over long periods.
"This is a sleeping-giant category, and it has been underestimated at every step," Androphy said.
A Women-Led Company Backed by Women-Led Funds
Allswell's raise also reflects the growing role of women-led investment firms in backing founders who might otherwise struggle to access capital. Rethink Impact focuses on companies with women and gender-diverse leaders, and Magnify Ventures, whose managing partner Julie Wroblewski said the firm was "proud to be investors", focuses on companies serving families and caregivers.
Women founders continue to receive a small share of venture funding in the United States, and healthcare companies serving marginalised communities often face additional scepticism about market size. Allswell's ability to raise a substantial seed round with strong early metrics offers a counterpoint to that narrative.
Plans for the New Capital
Allswell will use the funding to expand to new states, grow its clinical training programme and broaden the services available on its platform, including the planned addition of medication management.
Expanding a behavioural health service across state lines is complex. Therapists must be licensed in each state where patients are located, insurance contracts must be negotiated payer by payer, and Medicaid programmes vary significantly from state to state. Building a pipeline of trained, affirming clinicians will be essential to maintaining quality as the company grows.
A Mission With Commercial Discipline
The challenge for Allswell will be to scale without diluting the specialised care that defines it. Many mental health startups grew rapidly during the pandemic only to struggle with clinician burnout, patient churn and reimbursement pressures.
Allswell's model, built on insurance coverage, long patient relationships and a clearly defined community, offers a different path. If the company can sustain its retention and outcomes as it expands, it could demonstrate that culturally specific care is not just a mission-driven niche, but a viable and scalable segment of the broader behavioural health market.
